James Luu, MD
Retina Specialist · Colorado Springs, CONPI 1174508071
Payments from drug & device makers
Across 973 payments — averaging $2988.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$1.8M
- Novartis$792K
- Bayer$218K
- Genentech, Inc.$116K
- US Retina LLC$6K
- Genentech USA, Inc.$2K
- plus $3K from 16 others
Across 4 payments — averaging $86.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$347
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 776 | $1,770,596 |
| Novartis | 5 | $792,092 |
| Bayer | 98 | $218,367 |
| Genentech, Inc. | 20 | $115,517 |
| US Retina LLC | 11 | $6,157 |
| Genentech USA, Inc. | 23 | $2,009 |
| Alcon | 11 | $1,044 |
| Alimera Sciences, Inc. | 4 | $369 |
| Amgen | 3 | $268 |
| Coherus Oncology, Inc. | 2 | $241 |
| Harrow Eye, LLC | 2 | $161 |
| Apellis Pharmaceuticals, Inc. | 2 | $142 |
| AbbVie(2 entities) | 5 | $138 |
| Eyepoint US, Inc. | 2 | $137 |
| Biogen | 1 | $133 |
| Sandoz | 1 | $116 |
| Astellas Pharma US Inc | 1 | $97 |
| Bausch & Lomb Americas Inc. | 1 | $59 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $24 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Optos, Inc. | 2 | $16 |
How this compares
$2,907,738 in reported general payments places this provider in the 95th percentile of 51 retina specialist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Colorado Springs
- Ramin SarrafizadehColorado Springs$1.7M
- Mark ChittumColorado Springs$1.2M
- Stanford TaylorColorado Springs$879K
- Cecinio RonquilloColorado Springs$175K
- Jonathan WilliamsColorado Springs$73K
- Adam MartidisColorado Springs$48K
- Amar ManninaColorado Springs$2K
- Sara HaugDurango$9.5M
- Mimi LiuEnglewood$2.2M
- Murtaza AdamParker$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.